US health spending growth slows on generics advance

by | 12th Jan 2006 | News

US health care spending growth slowed for the second straight year in 2004, with a rise of 7.9% compared with 8.2% in 2003 and 9.1% in 2002, says the Office of the Actuary at the US Centers for Medicare and Medicaid Services’ annual report.

US health care spending growth slowed for the second straight year in 2004, with a rise of 7.9% compared with 8.2% in 2003 and 9.1% in 2002, says the Office of the Actuary at the US Centers for Medicare and Medicaid Services’ annual report.

US health care spending totaled $1.9 trillion in 2004, or $6,280 per person, while the share of US Gross Domestic Product spent on health care grew 0.1 percentage point to 16.0%, a smaller increase than in recent years, it says.

Prescription drugs accounted for 11% of the growth in national health care expenditures In 2004, a smaller share of the increase than in recent years, while drug spending’s 8.2% rate of growth for the year was also slower in absolute terms than in previous years – 10.2% in 14.3% in 2000-2. Moreover, while drugs accounted for 23% of personal health spending growth during 1997-2000, by 2002-4 they represented just 14%.

US federal, state and local government spending on health care rose 8.2% in 2004, says the study. Public expenditure continues to be dominated by Medicare ($309 billion in 2004), where growth rebounded in 2004 partly due to the Medicare Prescription Drug, Improvement and Modernization Act of 2003. Medicaid spending reached $291 billion in 2004, to account for 15% of total national health care expenditures but with growth decelerating from 8.8% in 2003 to 7.9%. This, says the report, reflects continued cost-containment efforts by US states which contributed to a marked slowdown in spending growth for prescription drugs.

Factors contributing to the slowing trend in drug spending were: rapid growth in the use of generics through tiered benefit plans; increased use of over-the-counter anti-ulcerants and antihistamines; a shift towards mail-order dispensing; and reduced consumption of certain drugs on safety concerns. In contrast to the overall trend, growth in out-of-pocket spending on pharmaceuticals outpaced private health insurance spending growth for drugs in 2003 and 2004, says the CMS.

Tags


Related posts